NCT03035032 2024-11-26
A Study of ELIGARDĀ® in Hormone-dependent Prostate Cancer Patients
Astellas Pharma Inc
Phase 4 Completed
Clinical Trials
6 trialsNCT05304169 2022-03-31
PRIZE
Zodiac Produtos Farmaceuticos S.A.
Phase 4 Completed
NCT01933022 2017-03-09
EFFECT
Astellas Pharma Inc
Phase 4 Terminated
NCT02749825 2016-04-25
Comparison of Trelstar Versus Lupron or Zoladex in Advanced Prostate Cancer
Pharmatech
Phase 4 Terminated
NCT01161563 2013-09-06
Randomized Crossover Trial to Assess the Tolerability of Gonadotropin Releasing Hormone (GnRH) Analogue Administration
Watson Pharmaceuticals
Phase 4 Completed
NCT00805935 2012-01-27
MenopurĀ® Versus FollistimĀ® in Polycystic Ovarian Syndrome (PCOS)
Ferring Pharmaceuticals
Phase 4 Completed